Ultragenyx Pharmaceutical, Inc. (RARE)
16.42
+0.99
(+6.42%)
USD |
NASDAQ |
Nov 09, 16:00
16.42
0.00 (0.00%)
After-Hours: 17:55
Ultragenyx Pharmaceutical Gross Profit (Annual) : 537.00M for Dec. 31, 2025
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 537.00M |
| December 31, 2024 | 453.46M |
| December 31, 2023 | 366.83M |
| December 31, 2022 | 320.01M |
| December 31, 2021 | 322.16M |
| December 31, 2020 | 252.64M |
| December 31, 2019 | 86.17M |
| December 31, 2018 | 30.81M |
| Date | Value |
|---|---|
| December 31, 2017 | -3.214M |
| December 31, 2016 | 0.00 |
| December 31, 2015 | -1.384M |
| December 31, 2014 | -0.684M |
| December 31, 2013 | -0.444M |
| December 31, 2012 | -0.313M |
| December 31, 2011 | -0.034M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Ionis Pharmaceuticals, Inc. | 915.36M |
| AbbVie, Inc. | 42.89B |
| Krystal Biotech, Inc. | 360.36M |
| BridgeBio Pharma, Inc. | 478.38M |
| Alnylam Pharmaceuticals, Inc. | 3.032B |